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Abstract
Background: The neuronal ceroid lipofuscinoses (NCL) are a group of children's inherited
neurodegenerative disorders, characterized by blindness, early dementia and pronounced cortical atrophy.
The similar pathological and clinical profiles of the different forms of NCL suggest that common disease
mechanisms may be involved. To explore the NCL-associated disease pathology and molecular pathways,
we have previously produced targeted knock-out mice for Cln1 and Cln5. Both mouse-models replicate
the NCL phenotype and neuropathology; the Cln1-/- model presents with early onset, severe
neurodegenerative disease, whereas the Cln5-/- model produces a milder disease with a later onset.
Results: Here we have performed quantitative gene expression profiling of the cortex from 1 and 4
month old Cln1-/- and Cln5-/- mice. Combined microarray datasets from both mouse models exposed a
common affected pathway: genes regulating neuronal growth cone stabilization display similar aberrations
in both models. We analyzed locus specific gene expression and showed regional clustering of Cln1 and
three major genes of this pathway, further supporting a close functional relationship between the
corresponding gene products; adenylate cyclase-associated protein 1 (Cap1), protein tyrosine
phosphatase receptor type F (Ptprf) and protein tyrosine phosphatase 4a2 (Ptp4a2). The evidence from
the gene expression data, indicating changes in the growth cone assembly, was substantiated by the
immunofluorescence staining patterns of Cln1-/- and Cln5-/- cortical neurons. These primary neurons
displayed abnormalities in cytoskeleton-associated proteins actin and β-tubulin as well as abnormal
intracellular distribution of growth cone associated proteins GAP-43, synapsin and Rab3.
Conclusion: Our data provide the first evidence for a common molecular pathogenesis behind neuronal
degeneration in INCL and vLINCL. Since CLN1 and CLN5 code for proteins with distinct functional roles
these data may have implications for other forms of NCLs as well.
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The Neuronal Ceroid Lipofuscinoses (NCLs) are the most
common group of inherited neurodegenerative diseases
of children, with an estimated worldwide incidence of
1:12,500. Affected individuals suffer from visual impair-
ment, seizures and dementia leading to early death [1].
The NCLs are a group of lysosomal storage disorders and
display a characteristic accumulation of lysosomal
autofluorescent lipopigments with a distinct ultrastruc-
ture in each form of NCL [2]. Targeted knock out mouse
models of different forms of NCL also display broadly
similar pathological findings: cortical atrophy, loss of
GABAergic interneuron subpopulations, loss of thalamic
relay neurons and pronounced gliosis [3-11]. However,
the precise nature and timing of these events differs mark-
edly between the different forms of NCL.
The NCLs are classified on the basis of the age of onset,
clinicopathological features and genetic linkage, to ten
different subtypes (CLN1-CLN10) and seven genes have
so far been identified. Two very severe, early onset forms,
CLN1 and CLN2 are caused by deficiencies of a lysosomal
enzyme, palmitoyl protein thioesterase 1 (PPT1) and
tripeptidylpeptidase 1 (TPP1) respectively [12,13]. The
phenotypically milder forms CLN3, CLN5, CLN6 and
CLN8, are caused by mutations in genes encoding pro-
teins of unknown functions [14-20]. In addition, the defi-
ciency of cathepsin D causes a congenital form of NCL,
currently denoted as CLN10 [21]. The precise mecha-
nisms by which mutations in these genes result in a dra-
matic neuronal degeneration are still unknown, but the
broadly similar pathological and clinical profiles of the
different NCLs suggest that common molecular pathways
might link these diseases together, despite having a differ-
ing primary cause. Nevertheless solid evidence for molec-
ular links between different forms of NCL is still scant.
However, CLN5 is shown to interact both with the CLN3
and the CLN2 proteins [19].
To gain insights into the molecular pathogenesis of the
various NCLs we have recently generated mouse models
of the Infantile Neuronal Ceroid Lipofuscinosis (INCL,
CLN1) and the Finnish variant form of Late Infantile Neu-
ronal Ceroid Lipofuscinosis (vLINCLFin, CLN5). The com-
mon pathological theme in both INCL and vLINCLFin is
the dramatic cortical atrophy, the origin of which has
remained elusive in the human studies [1,2]. These Cln1-
/- (Ppt1Δex4) and Cln5-/- mice replicate the appropriate
clinicopathological presentation of human INCL and
vLINCLFin, respectively. Cln1-/- mice exhibit a severe, early
onset disease, whereas Cln5-/- mice display a much milder
NCL-like phenotype. Both of these models show charac-
teristic ultrastructural findings, namely granular osmi-
ophilic deposits (GRODs) in the Cln1-/- and curvilinear as
well as fingerprint profiles in the Cln5-/- mice [5,6].
Here we have studied one month and four month old
Cln1-/- (Ppt1Δex4) [5] and Cln5 -/- [6] mice to address the
issue of a "shared common pathway" behind neurodegen-
erative changes in these two forms of NCL. In both mouse
models global transcript profiling of the cortex revealed
prominent alterations in genes involved in protein phos-
phorylation. Interestingly, the changes specific for Cln1-/-
mice were associated with genes involved in neurogenesis
and calcium homeostasis, whereas changes specific for
Cln5-/- mice involved genes responsible for myelination
and RNA processing. Comparing the data from both mice
exposed 51 common genes, many of which were involved
in a shared pathway affecting the neuronal growth cone –
cytoskeletal dynamics. We utilized a custom-made tool to
analyze locus specific gene expression and observed clus-
tering of the key genes of this pathway, together with Ppt1/
Cln1. Subsequent immunofluorescence analysis of corti-
cal neurons further supported these findings, thus provid-
ing the first evidence for a shared molecular mechanism
behind neuronal degeneration in the different forms of
NCL.
Methods
Animals
Homozygous mutant Cln1-/- (Ppt1Δex4) mice [5] and
Cln5-/- [6] mice were maintained on the same mixed
C57BL/6Jx129SvEv strain background. All animals used
in this study were a result of five generations of backcross-
ing onto C57BL/6J. We used systematically sampled brain
tissue from 1 and 4 month old male mice for all experi-
ments and wild-type littermate mice were used as controls
for each mutant strain. The genotypes of the mice were
determined by PCR of DNA from tail biopsies [5,6]. All
animal experiments were performed in accordance with
approved animal policies of the National Public Health
Institute, Helsinki.
Histological processing and immunohistochemistry
For histological analysis, 1 and 4 month old male Cln5-/-
, Cln1-/- and age-matched control mice (n = 3/genotype)
were sacrificed in a rising concentration of carbon diox-
ide, where after their brains were removed and bisected
along the midline. One half of the bisected brain was fro-
zen in liquid nitrogen and stored in -70°C and the other
half was immersion fixed in 4% paraformaldehyde. Sub-
sets of the brains were embedded in paraffin and 5 μm
coronal sections where cut through the cerebrum and
processed further as described previously [3]. Paraffin sec-
tions were immunohistochemically stained for β-tubulin
III (Chemicon, 1:200) and F-actin (Alexa Fluor 488 Phal-
loidin, Molecular Probes) using a standard protocol [5].
Quantitative tresholding image analysis
The expression of β-tubulin isoform III, and actin was
measured by quantitative thresholding image analysis asPage 2 of 14
(page number not for citation purposes)
BMC Genomics 2008, 9:146 http://www.biomedcentral.com/1471-2164/9/146previously described [3], with each marker analyzed blind
with respect to genotype. 40 nonoverlapping images, on
triplicate sections, were captured through each selected
brain region and the optimal segmentation of immunore-
active profiles was determined using Image Pro-Plus image
analysis software (Media Cybernetics) using a previously
described semi-automated thresholding method based on
the optical density of the immunoreactive product [3].
Macros were recorded to transfer the data to a spreadsheet
for subsequent statistical analysis. Data were separately
plotted graphically as the mean percentage area of immu-
noreactivity per field ± S.E.M. for each region.
Gene expression profiling of the cortex
The remaining half of each bisected brain from 1-month-
old and 4-month-old male Cln1-/-, Cln5-/- and age-
matched control mice were used for gene expression pro-
filing. To average out the inter-individual variability, RNA
extracted from the entire cortical area of eight Cln1-/-
mice, eight wild-type littermates, eight Cln5-/- mice and
eight of their wild-type littermates, was pooled together
into two wild-type and two knock-out samples per disease
state. Thus, each pool contained RNA from four different
mice and two pools were analyzed as replicates for each
genotype. 5 μg of total RNA was labeled and fragmented
according to the manufacturer's instructions (Affymetrix,
Santa Clara, CA). Gene expression profiles were deter-
mined using the Affymetrix Mouse MOE 430A array
(Affymetrix, Santa Clara, CA). Hybridization, post-
hybridization washes, staining and scanning were per-
formed as described previously [5]. Data normalization,
filtering and determination of significance cut-offs were
performed following rigorous standards, optimized to
achieve a minimum of false positive discoveries [5].
Briefly, normalization was carried out using the Robust
Multichip Average (RMA) model implemented in the R
package Affy, using default settings. The normalized data
was imported into the GeneSpring 6.0 data analysis soft-
ware (Silicon Genetics, Redwood City, CA). Only probe
sets scored as "present" by the Affymetrix MAS 5 algo-
rithm in at least two of the four arrays passed the first fil-
tering step, a second filter was applied to remove genes
exhibiting inconsistent results across the two biological
replicate samples representing each genotype. Expression
values were averaged over the replicates and log-trans-
formed to assure normally distributed values. Values dif-
fering at least two standard deviations from the mean
were considered indicative a significant difference in
expression.
Gene Expression Pathway Analysis
In order to analyze the affected biological entities that
may not have been defined by significant individual gene
expression changes, a custom made non-parametric path-
way analysis algorithm (related to [22]) was employed
using the gene annotation data from the GeneOntology
Consortium [23]. The Affymetrix "present" tagged probe
sets were ranked by the median fold change values
between wild type and Cln1/5 knock out mice to "upregu-
lated" and "downregulated" vectors. The probe sets were
then mapped to mouse genes using cross-references in
Ensembl database and their associated GO annotations
were collected. Our algorithm also utilized the directed
topology of the GO-tree by traversing all available routes
to the root of the GO tree and all encountered vertexes
were added as GO annotations for the given gene. For
detection of affected GO gene groups (here called "path-
ways"), an iterative cumulative hypergeometric distribu-
tion p-value based calculation was used, where the
objective is to find the optimum p-value for a set of genes
which belong to the same annotated GO gene collection
(maximal regulation for the pathway). The algorithm
works by traversing through the ranked list of genes and at
every occurrence of a gene belonging to the given path-
way, the hypergeometric p-value is calculated, answering
the question "how likely is it to see this many genes (k)
that belong to the studied pathway this high-up in the
ranked list of genes (j), when there are altogether t genes
that belong to the pathway amongst n genes in the exper-
iment" (see (1)).
Further, exhaustive permutations by randomizing the
gene ranks was done for each GO category, followed by an
interpretation of an empirical p-value from the distribu-
tion of 10,000 permutation cycles.
Locus Specific Gene Expression Analysis
The locus specific gene expression data analysis was done
by first mapping the Affymetrix probe sets to their corre-
sponding genes in the mouse genome in Ensembl data-
base version 43. The Affymetrix "present" tagged probe
sets were then ranked as "upregulated" and "downregu-
lated" between wild type and Cln1/5 knock out mice by
calculating median fold changes. The probesets for Cln1
and Cln5 were removed from the analyses of Cln1-/- and
Cln5-/- mice, respectively. Next the gene expression at
each locus of the mouse genome was systematically stud-
ied. Briefly, by starting at each gene along each mouse
chromosome, each referred mouse gene was used as a
starting point for a locus. The length of a given locus was
systematically extended, ranging between 5,000 to
20,000,000 base pairs and 2 to 100 genes. Each generated
locus containing t genes within those limits was analyzed
for regulation of expression by a similar iterative hyperge-
p j k t n
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Analysis. The t i.e. how many genes belong to the locus,
was optimized as the number providing the strongest reg-
ulation for the given locus (that is, the regulation of
expression of the locus was represented by a length of the
locus that was within the given locus size boundaries and
provided the strongest regulation). This search was
repeated using all the mouse genes as locus starting points
and an optimal regulation for these was calculated. Fur-
ther, in addition to the nominal p-values, empirical p-val-
ues were calculated for all studied loci sizes (2...100
genes) each with 10,000 permutations using randomized
gene/probeset ranked lists.
Neuronal cell culture and immunofluorescence staining
E15.5 primary cortical neuron cultures were prepared
from Cln1-/-, Cln5 -/- and wild type control mouse
embryos as described previously [24]. For immunofluo-
rescence staining, the neurons were grown on coverslips
for eight days and were then fixed with 4% paraformalde-
hyde in PBS, permeabilized and immunostained as
described previously [25]. The primary antibodies used
were anti Synapsin 1 and 2 rabbit antiserum and mouse
monoclonal anti Rab 3 (Synaptic Systems GmbH, 1:100
and 1:1000 respectively), Gap43 (1:1000) and mouse
monoclonal anti β-tubulin, isoform III (Chemicon,
1:200). Alexa Fluor 488 Phalloidin (Molecular probes, as
recommended by the manufacturer) was used for visual-
izing F-actin. The coverslips were mounted in GelMount
(Biomeda Corp., Foster City, CA) and viewed with a Leica
SP confocal microscope. The analyses were performed
from three different preparative batches of neurons with
duplicate immunostainings from each batch.
Mouse brain membrane preparation and Western blotting
Flash frozen brains were homogenized in a buffer (2.5
mM KCl, 250 mM sucrose, 25 mM HEPES pH 7.4, pro-
tease, and 2 mM DTT) and separated into membrane and
cytoplasmic fractions as described previously [26]. The
membrane and cytoplasmic fractions were electro-
phoresed on 14% SDS-PAGE gels and transferred onto
nitrocellulose membranes by electroblotting. The immu-
nostaining was performed with primary antibodies for
Synapsin 1, synapsin 1+2 rabbit antiserum (1:1000) and
mouse monoclonal anti Rab 3 (1:100), Gap43 (1:1000)
and mouse monoclonal anti β-tubulin, isoform III
(1:200). HPR-conjugated secondary antibodies were used
diluted to 1:5000. Western blotting was performed as rec-
ommended by the manufacturer (Amersham Bio-
sciences). The analyses were repeated twice.
Results
Gene expression profiling of the cortex reveals differential 
expression of genes with known functions in neuronal 
signaling and structure
Human as well as other vertebrate NCL diseases are typi-
fied by local astrocytic activation and a gross upregulation
of inflammation related genes in the later stages of disease
progression [5,6]. Here we have addressed the global
changes in transcript profiles in the cerebral cortex of the
Cln1-/- and Cln5-/- mice with the hypothesis that this
would provide us with clues of critical metabolic path-
ways that contribute to the neurological phenotype and
neuronal degeneration.
The Cln1 -/- mouse
The combined analysis of the replicate microarray data-
sets from the cortex of 1 month old Cln1-/- mice revealed
a total of 417 differentially expressed genes compared to
controls, of which 261 were upregulated and 156 down-
regulated (see Additional file 1, see methods). None of
the upregulated genes exceeded a fold change of 2, the
most upregulated gene being cytotoxic granule-associated
RNA binding protein 1 (Tia1, fold change of 1.6). The
most downregulated gene was Cln1 (Ppt1 with a fold
change of -3.5) followed by protein tyrosine phosphatase
receptor type F (Ptprf, fold-change of -2.2).
Similar analysis of 4 month old Cln1-/- and control mice
revealed 164 differentially expressed genes, of which 137
were upregulated and only 27 downregulated (see Addi-
tional file 1). The most upregulated gene was adenylate
cyclase-associated protein 1 (Cap1) being over 32-fold
upregulated, followed by glial fibrillary acidic protein
(Gfap), which was 16.6-fold upregulated. Most downergu-
lated genes included inactive X specific transcripts (Xist),
G protein-coupled receptor, family C, group 5, member B
(Gprc5b) and Ptprf (with fold changes of -7.0, -3.7 and -3.3
respectively).
The Cln5 -/- mouse
Analysis of the datasets of 1 month old Cln5-/- mice
revealed 283 differentially expressed genes compared to
controls, with 76 up- and 206 downregulated genes. In
the cortex of Cln5-/- mice, the most upregulated gene was
Cap1 (3.9-fold increased), the same gene that was identi-
fied as the most upregulated in 4 month old Cln1-/- mice
(see Additional 1). The most downregulated gene was
chemokine (C-C motif) ligand 21a (Ccl21a), with a fold
change of – 1.7.
At the age of 4 months, 114 differentially expressed genes
were revealed in Cln5-/- mice, of which 34 were upregu-
lated and 80 downregulated. The most prominent change
was the -6.4 fold downregulation of kinesin family mem-
ber 5C (Kif5c), followed by DEAD (Asp-Glu-Ala-Asp) boxPage 4 of 14
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tively). The most upregulated gene was dentatorubral-pal-
lidoluysian atrophy protein (Drpla) with a fold change of
4.1 (see Additional file 1). The results of the gene expres-
sion profiling of both Cln1-/- and Cln5-/- datasets were
validated by quantitative real-time PCR analysis of
selected genes (data not shown).
Combined analyses reveal that neuronal growth cone and 
axon guidance pathways are differentially expressed in 
both CLN1 and CLN5
Single gene analysis
To address the "common molecular pathways" affected in
both mouse models, we aimed to identify sets of genes
that showed similar patterns of changes in gene expres-
sion in both Cln1-/- and Cln5-/- mice. Comparison of the
microarray data sets revealed 51 genes that were differen-
tially expressed in both models (Table 1). Among these we
could further pinpoint genes that encode for proteins crit-
ical for the neuronal growth cone – cytoskeletal dynamics,
including Ptprf, rous sarcoma oncogene (Src), Cap1, pro-
tein tyrosine phosphatase 4a2 (Ptp4a2), Kif5c, contactin
associated protein 1 (Cntnap1, p190) and the Cdk5 regu-
latory subunit p35 (Cdk5r1). These proteins may further
link the growth cone and cytoskeletal dynamics to axon
guidance/growth via the ras homolog gene family, mem-
ber A (RhoA), cell division cycle 42 homolog (Cdc42) and
RAS-related C3 botulinum substrate 1 (Rac1). The protein
products of the differentially expressed genes in the com-
mon affected pathway are shown in Fig 1.
Functional classes
In order to analyze the affected biological pathways,
which may not be defined by significant individual gene
expression changes, a custom made non-parametric path-
way analysis algorithm was employed. When analyzing
the differentially expressed genes of the 1 month old Cln1-
/- mice we found several functional classes to be signifi-
cantly regulated. The most pronounced alterations were
seen in genes related to development of neuronal entities,
followed by signaling pathways related to phosphoryla-
tion and calcium ion homeostasis (Fig 2). When analyz-
ing the 4 month old Cln1-/- mice we discovered
upregulation of inflammation associated pathways. In
addition, we found that Calcium homeostasis, Cytoskeleton
Common affected pathways in Cln1 and Cln5 deficient mouse modelsFigure 1
Common affected pathways in Cln1 and Cln5 deficient mouse models. A schematic picture of protein-protein inter-
actions between genes that are differentially expressed in both mouse-models. Upregulated genes are shown in red and down-
regulated genes in green. Genes with no changes in expression are shown in blue. Genes with changes only in one replicate 
experiment are shown in pink.
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categories (Fig 2).
Our analysis of the 1 month old Cln5-/- mice revealed reg-
ulation of cell adhesion, RNA processing and transcrip-
tion, as well as phosphorylation related pathways (Fig 2).
In the 4 month old Cln5-/- dataset our analysis pinpointed
Table 1: Differentially expressed genes in both Cln1-/- and Cln5-/- mice at 1 and 4 months of age. Double/triple values indicate multiple 
appearances in the gene expression data.
ID number Cln1 1 mo Cln1 4mo Cln5 1mo Cln5 4mo Symbol
NM_011213 -2,2/-1,8 -3,3/-1,9 -1,3 2,6/2,5 Ptprf
BE134116 -1,5 3,8 1,7 -3,7 Ptp4a2
AF378831 -1,2 -3,7 1,6 -5,7 Gprc5b/raig2
BC023103 1,5/1,3 2,7 4,0 Camkk2
AI844677 -1,5 2,1 -6,4 Kif5c
BC021452 -1,2 2,2 -3,2/-6,0 Ddx6
BG071068 1,3 -2,4 -5,0/-3,4 Gnb1
BB647052 1,3 1,8 1,5 Tex261
BG065186 -1,2/-1,3 2,3 1,4 Ywhaz
BM214109 2,6 -1,3 -2,5 Tpr
BI692255 -1,5 -1,3 -3,8 Prkwnk1
BE447456 -1,2 -1,3/-1,5 -2,7 Khdrbs1/sam68
AI788623 1,3 -1,4 -3,6/-2,7 Ramp2
AY026947 -1,3 -1,3 -2,6 Rab3c
AU080702 1,3 2,8 Mapt
BG962849 1,5 2,7 Foxp1
AK002933 1,2 2,6 Nrgn
AU067745 1,2 2,6 Elavl3
BE952057 1,2 2,5 Fscn1
U00689 1,6/1,3 2,5 Tia1
AV139249 1,3 2,4 Bsn
BB419318 -1,3 -3,5 Gda
BB283759 -1,3 -3,5 Csnk2a1
AV083741 -1,3 -3,4 Mtdh
NM_018733 -1,2 -3,0 Scn1a
NM_008066 -1,3 -2,7 Gabra2
AW060288 -1,2 -2,6 Qk
NM_008845 -1,2 -2,5 Pip5k2a
BG067003 -1,2 -2,4 Zrf2
BC005446 32,2 3,9/3,2 Cap1
NM_018798 2,4 1,3 Ubqln2
BM224327 2,4 1,3 Fcgr2b
BB538325 2,2 -1,4 Ccnd1
AV102733 1,8 -1,3 Scpep1
AW049660 -1,9/-1,8 -1,3 Nfix
AV147875 2,3/2,7/2,9 -3,1 Vim
AF363030 2,9 3,2 Ogt
AJ457190 2,3 3,4 Phospho1
NM_007881 2,1 4,1 Drpla
NM_016782 2,1 3,3 Cntnap1
BG868120 2,0 2,4 Src
NM_016789 1,2 1,7 Nptx2
AA673371 1,4/1,3/1,2 1,4 4933439C20Rik
NM_010444 1,2 1,3 Nr4a1
AK019164 -1,2 -1,5 Mpdz
BC006680 -1,2 -1,4/-1,3 Ubc
NM_016916 -1,2 -1,3 Blcap
AF370126 -1,3 -1,3 Dner
NM_011599 -1,5 -1,3 Tle1
BB429612 1,2 -1,3 Scn8a
BQ175532 -1,2 -1,3/-1,4 Ahi1Page 6 of 14
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Gene expression differences according to gene ontology classes in: Cln1-/- 1mo array, Cln1-/- 4mo array, Cln5-/- 1mo array, Cln5-/- 4mo arrayFigur  2
Gene expression differences according to gene ontology classes in: Cln1-/- 1mo array, Cln1-/- 4mo array, Cln5-/
- 1mo array, Cln5-/- 4mo array. All the significant categories are shown.
Cln1 1mo  Cln1 4mo  
Biological process p-value
permuted 
p-value Biological process p-value
permuted 
p-value
locomotory behavior      6.1E-06 0.0001 homeostatic process      1.0E-06 0.0001
axonogenesis      8.4E-06 0.0003 cellular cation homeostasis      6.1E-06 0.0001
neuron morphogenesis during 
differentiation      9.1E-06 0.0002 cellular ion homeostasis      1.2E-05 0.0007
neurite morphogenesis      9.1E-06 0.0002 di-, tri-valent inorganic cation homeostasis   1.3E-05 0.0003
cellular morphogenesis during 
differentiation      2.1E-05 0.0008 cellular metal ion homeostasis      1.8E-05 0.0003
neuron differentiation      2.2E-05 0.0006 cellular homeostasis      1.9E-05 0.0004
neurite development      3.0E-05 0.0003 ion homeostasis      2.7E-05 0.0005
generation of neurons      4.0E-05 0.0011 cytoskeleton organization and biogenesis     2.1E-06 0.0001
neurogenesis      5.9E-05 0.0015 intermediate filament-based process      6.5E-05 0.0001
neuron development      7.6E-05 0.0013
cortical cytoskeleton organization and 
biogenesis      7.2E-05 0.0006
cell adhesion      1.4E-05 0.0006 receptor mediated endocytosis      1.3E-05 0.0002
protein autoprocessing      2.0E-05 0.0001 water transport      4.8E-05 0.0001
protein amino acid autophosphorylation      2.0E-05 0.0004 fluid transport      4.8E-05 0.0002
calcium ion homeostasis      6.3E-05 0.0006 nervous system development      5.5E-05 0.0014
inorganic anion transport      6.9E-05 0.001
Molecular function Molecular function
protein serine/threonine kinase activity      2.7E-06 0.0002 cytoskeletal protein binding      1.5E-06 0.0002
protein kinase activity      1.5E-05 0.0005 protein tyrosine phosphatase activity      1.1E-05 0.0006
lipid transporter activity      6.4E-05 0.0004 antioxidant activity      1.3E-05 0.0002
water transporter activity      4.8E-05 0.0003
response to other organism      1.0E-11 0.0001
and other related clases
Cellular component Cellular component
axonemal dynein complex      1.9E-05 0.0001 lysosome      5.6E-08 0.0001
axoneme part      1.9E-05 0.0001 lytic vacuole      5.6E-08 0.0001
axoneme      1.9E-05 0.0002 vacuole      2.7E-07 0.0001
cell projection part      4.3E-05 0.0005 actin cytoskeleton      4.3E-05 0.0007
integral to plasma membrane      5.6E-05 0.0012
intrinsic to plasma membrane      7.1E-05 0.0016
Golgi apparatus      6.3E-05 0.0009
secretory granule      6.5E-05 0.0008
Cln5 1mo  Cln5 4mo  
Biological process p-value
permuted 
p-value Biological process p-value
permuted 
p-value
cell adhesion      2.5E-06 0.0007  camera type eye morphogenesis      4.7E-05 0.0002
protein autoprocessing      8.1E-06 0.0002 nerve ensheathment      6.0E-05 0.0007
protein amino acid autophosphorylation      8.1E-06 0.0001
mRNA metabolism      1.8E-05 0.0002
positive regulation of transcription      2.4E-05 0.0006
nucleoside, nucleotide and nucleic acid 
metabolism      3.8E-05 0.0009
positive regulation of cellular metabolism     4.6E-05 0.0011p
dependent      5.3E-05 0.0008
positive regulation of metabolism      5.9E-05 0.0014
RNA splicing      7.3E-05 0.0013
mRNA processing      8.1E-05 0.0024
biogenic amine metabolism      3.4E-05 0.0002
amino acid derivative metabolism      6.8E-05 0.0016
Molecular function Molecular function
transcription factor activity      1.2E-05 0.0005 structural constituent of myelin sheath      1.9E-06 0.0001
response to chemical stimulus      2.1E-05 0.0007 unfolded protein binding      1.4E-05 0.0003
Cellular component Cellular component
cytosol      2.7E-05 0.0009
cilium part      3.4E-05 0.0002
ciliary rootlet      3.4E-05 0.0004
proteasome complex       4.9E-05 0.0006
ribonucleoprotein complex      6.7E-05 0.0013
BMC Genomics 2008, 9:146 http://www.biomedcentral.com/1471-2164/9/146regulation in nerve ensheatment/myelination as well as in
and camera eye development (Fig 2).
Collectively, the transcript profiling of both Cln1-/- and
Cln5 -/- mice highlighted changes in genes involved in
phosphorylation. Additionally, changes in neurogenesis
and calcium homeostasis associated genes were more pro-
nounced in young Cln1-/- mice whereas changes in the
expression of genes associated with myelination and RNA
processing characterized the Cln5-/- mice.
Co-regulation of multiple genes in the Cln1 genetic locus
Interestingly, three key players of the identified neuronal
growth cone/axon guidance pathway are located in close
proximity of the Cln1 gene in the mouse genome, poten-
tially indicating a close functional relationship or even
interdependence between these gene products. As the
same set of genes is differentially expressed also in the
Cln5-/- mouse, we ruled out the possibility of this being
due to knocking out the Cln1 gene and therefore affecting
possible regulatory regions of these other genes. Ptprf,
Ptp4a2 and Cap 1 (Table 1) are located in the vicinity of
the Cln1 gene on mouse chromosome 4 (Fig 3), with a
similar clustering of these four genes on the human chro-
mosome 1q32. To assess the relevance of this finding, we
used an in-house developed data analysis tool for locus
specific gene expression. We searched for coordinated reg-
ulation of gene expression at each locus of the mouse
genome, with size limits ranging from 5000 to
20,000,000 base pairs. This analysis revealed that the
most significantly affected locus in the Cln1-/- mouse
datasets was 4D2.2 in both 1 month and 4 month old
mice. The most significant area on 4 D2.2 in the 1 month
Cln1 dataset was flanked by Ptp4a2 and splicing factor
proline/glutamine rich (Sfpq) (nominal p = -4.1 × 10-7;
permuted p = 2.0 × 10-5). Other highly significant clusters
were found in the 4D1 area, surrounding the Ppt1 locus,
ranging from Ptprf to NADH dehydrogenase (ubiqui-
none) Fe-S protein 5 (Ndufs5) (nominal p = -8.1 × 10-6;
permuted p = 1.9 × 10-4). (Fig 3). The most significant area
on 4 D2.2 in the 4 month Cln1 dataset was flanked by lys-
osomal-associated protein transmembrane 5 (Laptm5)
and zinc finger and BTB domain containing 8 opposite
(Zbtb8os) (nominal p = -4.5 × 10-9; permuted p = 1.0 ×
10-6). (Fig. 3). Another significant locus was found on 4
D3. This locus included three complement component
genes, namely complement component 1, q subcompo-
nent, chains B, C and A (C1qb, C1qc and C1qa) (p = 1.6
× 10-8, permuted p = 4.0 × 10-6) (Fig. 3). No significant
clustering in these specific regions were found in the Cln5-
/- mouse dataset, although many of the genes located in
the same region were also differentially expressed in Cln5-
/- mice.
Currently, the functional significance of such gene cluster-
ing is unknown, but emerging data from other gene clus-
ters of the genome could imply that genes within
evolutionary preserved linkage groups retain their cluster-
ing since they code for proteins with critical functional
interactions. Since Ptprf, Cap1 and Ptp4a2, the genes
found in the clusters around Ppt1, are connected to the
same signaling pathway (Fig 1), and since they are differ-
entially expressed in both disease models, this may imply
a distinct functional relationship between these genes.
Taken together, a common affected signaling pathway
between Cln1-/- and Cln5-/- mice was revealed by a com-
bined analysis of transcript profiles (Fig 1). This pathway
is connected to phosphorylation and further affects the
cytoskeleton and growth cones in neurons. Additionally,
genes for the three key players of this pathway were shown
to be clustered on the same chromosomal region with the
Ppt1 gene, potentially indicating a close functional rela-
tionship or even interdependence between these gene
products.
Altered subcellular localization of proteins implicated in 
cytoskeletal dynamics and growth cone anatomy
Our gene expression profiling data with subsequent anal-
ysis of the affected biological pathways as well as utiliza-
tion of the locus-specific gene expression tool suggested a
potential impairment of protein phosphorylation genes
related to cytoskeleton-mediated growth cone anatomy in
Cln1 and Cln5 deficient mice. We assessed possible
changes in protein tyrosine phosphorylation between
knock out and wild-type control mice in western blot
analyses of CNS tissue but could not identify statistically
significant differences (data not shown).
To assess the putative defects in growth cone anatomy, we
first analyzed potential differences in the intracellular
localization or quantity of actin and tubulin, two gener-
ally utilized markers for initial characterization of the
integrity of neuronal projections. We performed double
immunofluorescence analysis of E15 primary cortical
neurons of wild type as well as Cln1 and Cln5 deficient
mice. Neurons from Cln1-/- mice displayed pronounced
actin staining in growth cones, but a relative lack of actin
and β-tubulin immunostaining in the cell soma, as com-
pared to controls (Fig 4), whereas neurons from Cln5-/-
mice exhibited particularly intense actin staining in the
neuronal soma and processes (Fig 4). Consistent with
these data, thresholding image analysis of immunohisto-
chemically stained brain sections revealed prominent
changes in actin immunostaining in the cortex of 1 and 4
month old Cln5-/- mice (Fig 4). Abnormal intracellular
localization of β-tubulin was not evident in stained cell-
cultures from Cln5-/- mice, but thresholding analysis of
brain sections revealed a significant reduction in the β-Page 8 of 14
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Chromosomal location of coregulated genesFigure 3
Chromosomal location of coregulated genes. Several differentially expressed genes show significant clustering in around 
Ppt1 on mouse chromosome 4, and might therefore be coregulated. The probesets for Ppt1 were excluded from the dataset 
and thus Ppt1 is shown in gray. The genes participating in the regulated loci or being independently regulated are shown, 
together with their location in base pairs in mouse chromosome 4. Genes that exhibit expression differences in both mouse 
models are indicated with *. Expression changes only in the Cln1-/- mouse are indicated with **.
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mals (Fig 4). Western blot analysis of soluble and mem-
brane-bound intracellular fractions from four months old
mice further demonstrated reduced levels of β-tubulin in
the cytoplasmic fraction of Cln5-/- mouse brains. In the
case of β-tubulin, the changes in gene expression profile,
indicating upregulation at 1 month old and no significant
change at 4 month Cln1-/- mouse cortex, did not translate
into the protein level.
To assess the potential aberrations in the intracellular
staining of growth-cone related proteins, we also immu-
nostained neuronal cultures from Cln1 and Cln5 deficient
mice for the growth cone assembly protein GAP-43 and
synapsin, two well known markers for growth cone integ-
rity, together with Rab3 which was differentially expressed
according to our transcript profiling data. These analyses
revealed that GAP-43 positive axonal varicosities were
remarkably sparse especially in the Cln1-/- neurons;
although intense membrane associated GAP-43 immuno-
reactivity was evident. This finding was confirmed by
western blot analysis, which revealed a more prominent
localization of GAP-43 in membrane-bound fractions in
both Cln1-/- and Cln5-/- mouse brains (Fig 5). Synapsin
immunostaining of Cln5-/- neurons revealed abnormal
membrane binding around the cell soma whereas the
Cln1-/- neurons showed abnormally faint Rab3 immuno-
reactivity, especially within neurites (Fig 5). These data
could indicate reduced amounts of these proteins within
cultured neurons, or alternatively may be a sign of their
mislocalization. Western blot analysis of soluble and
membrane bound fractions of brain tissue revealed fur-
ther changes in the processing and localization of syn-
apsins in Cln1-/- mice, but only negligible changes in
Cln5-/- mice. In contrast, Rab3 was almost completely
absent from the cytoplasmic fraction of Cln5-/- mice, but
appeared unchanged in Cln1-/- brains (Fig 5). These
results demonstrating altered subcellular distribution of
cytoskeleton and growth-cone related proteins in both
Cln1-/- and Cln5-/- neurons as well as brain tissue, provide
direct evidence for a functional significance of the abnor-
malities observed in transcript profiles and further sup-
port the observation that cytoskeletal and growth cone
mediated pathways are disturbed in INCL and vLINCL.
A) Immunofluorescence analysis of actin and β-tubulin staining in E15 primary cortical neurons of wt, Cln1-/- and Cln5-/- miceFigure 4
A) Immunofluorescence analysis of actin and β-tubulin staining in E15 primary cortical neurons of wt, Cln1-/- 
and Cln5-/- mice. Actin is visualized in green and β-tubulin in red. The overlay shows the colocalization of the two proteins 
in yellow. B) Quantitative threshold imaging of actin and β-tubulin staining in the Cln5-/- mouse brain. Significant p-values, with 
p < 0.05 are indicated with *. Ctx, cortex and cc, corpus callosum.Page 10 of 14
(page number not for citation purposes)
BMC Genomics 2008, 9:146 http://www.biomedcentral.com/1471-2164/9/146Discussion
In this report, we have explored the hypothesis that a
common molecular pathway may underlie some of the
aspects of neurodegeneration the characteristic feature of
neuronal ceroid lipofuscinoses. The developments of
mouse models for NCLs as well as the advancements of
microarray technologies have opened the way for discov-
ering affected molecular pathways on a genome-wide
scale. By using two mouse models of NCL; the Cln1-/-
(Ppt1Δex4) [5] and the Cln5-/- [6] mice, we investigated if
any evidence could be collected for shared molecular
pathways. At autopsy of NCL patients the cortex is the
most severely affected brain region, and hence we decided
to perform global transcript profiling of Cln1-/- and Cln5-
/- cortices. Previous data obtained from gene expression
profiling of Cln1-/- mouse cortex tissue has provided
information on the importance of neuroinflammation in
the late stage of the disease [5]. The transcript profiling of
Cln5-/- cortices has implicated inflammation and defects
in myelination at the ages of 3 and 4.5 months [6]. Com-
parisons between previous analyses of NCL mouse mod-
els suggested marked upregulation of inflammation and
neurodegeneration related genes in Cln1-/- and Cln3-/-
mice whereas the changes in the Cln5-/- mice were less
prominent at the level of individual gene expression
[27,28]. However, differences in the methods used made
the direct comparison between mouse models problem-
atic. Here we utilized simultaneous sample preparation,
rigorous microarray data filtration and a custom made
pathway analysis algorithm and were able to identify a
common affected biological pathway between the Cln1-/-
and Cln5-/- mouse models.
Currently the initial cascade of events leading to glial acti-
vation and neurodegeneration are unknown [5,6,29] and
therefore a global transcript profiling may provide an
insight into early events in the disease progression. The
comparison of two microarray data sets provides a means
to determine how changes in gene expression relate to
specific disease mechanisms. We identified a set of differ-
entially expressed genes which were connected to same
functional pathway in these two mouse models, and were
also able to detect some "model specific" distinct differ-
ences between the cortical expression profiles. These fea-
tures, potentially specific to each disease, included
significant changes in genes involved in neurogenesis and
calcium homeostasis (Cln1-/- mice) as well as genes
involved in myelination and transcription (Cln5-/- mice).
A) Immunofluorescence analysis of Synapsin, Rab3 and GAP-43 staining in E15 primary cortical neurons of wt, Cln1-/- and Cln5-/- miceFigure 5
A) Immunofluorescence analysis of Synapsin, Rab3 and GAP-43 staining in E15 primary cortical neurons of wt, 
Cln1-/- and Cln5-/- mice.B) Western blot analysis of cytoplasmic and membrane bound fractions of cytoskeletal, growth-
cone and synapse assembly proteins. Antibodies: β-tubulin, synapsin 1, synapsin 1&2, Rab3 and Gap43.Page 11 of 14
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not dramatically altered in the Cln1-/- mice but alterations
in calcium homeostasis were evident in two different Cln1
deficient mouse models [30,31]. Myelination related
changes were observed in our previous gene expression
profiling analyses of 3 and 4.5 month old Cln5-/- mice [6]
and were replicated here in the 4 month old Cln5-/- mice.
This finding is not unexpected since the loss of myelin is
a well-known feature in vLINCL patients [32,33]. Differ-
ential expression of genes relating to eye-development is
interesting and expected, since blindness is the first symp-
tom that can be observed in Cln5-/- mice [6]. However,
the most significant finding specific to Cln5-/- mice was
the differential expression of genes related to RNA
processing and transcription. It is currently not known
how this finding could relate to vLINCL, and further stud-
ies, specifically directed to systematic screening of RNA
processing and transcription will be needed.
Our data imply that changes in phosphorylation related
genes are common to both INCL and vLINCL. Interest-
ingly, three phosphorylation and cytoskeleton related
genes, differentially expressed in both mouse models,
cluster around Cln1 on mouse chr 4. In the present study
we have therefore developed a bioinformatic tool demon-
strating the statistical significance of this finding. Genes
that are part of the same metabolic pathway may be clus-
tered in the same chromosomal region. Such linkage
groups or gene clusters are not necessarily compact, but
may correspond to comparatively large regions with high
concentrations of functionally related or interdependent
genes [34]. We propose that the observed regional cluster-
ing of these genes provides further evidence for their func-
tional interactions and their link with Cln1 pathogenesis.
Even more importantly, the dysregulation of the same
genes in the Cln5-/- mouse cortex might implicate a link
between the two forms of NCL. Further studies with sys-
tematic sampling and global analyses of all the available
mouse models for NCLs (reviewed in [29]) should pro-
vide information on whether the differential expression of
this gene cluster represents a hallmark of NCL diseases in
general.
Several protein tyrosine kinases (PTKs) and protein tyro-
sine phosphatases (PTPs) showed significantly changed
expressions. One of the functions that PTKs and PTPs reg-
ulate is growth cone motility, axon outgrowth and guid-
ance [35]. Ppt1/Cln1 has been localized to axonal
presynaptic vesicles and is also present in neuronal
growth cones [24,36], suggesting a role for this soluble
enzyme in these cellular compartments. Indeed, our
immunofluorescence data suggest that the subcellular dis-
tribution of the growth cone specific GAP-43 protein is
perturbed in Cln1 deficient cortical neurons. This feature
is shared by Cln5 deficient neurons and suggests that a
defect in growth cone anatomy may be common to these
two forms of NCL.
Our transcript profiling also revealed a downstream
impact of Cln1 and Cln5 deficiency upon the cytoskele-
ton. This was substantiated by cytoskeletal aberrations in
the pathway analysis of the Cln1-/- mice and by signifi-
cantly changed expression levels of individual actin and
microtubulus-related genes in the Cln5-/- mice. This influ-
ence extended to a redistribution of actin that was most
pronounced in the Cln5-/- mice. These data are consistent
with recent observations in a mouse model of juvenile
NCL, caused by the deficiency of CLN3 transmembrane
protein, which is also linked to cytoskeletal abnormalities
and intracellular trafficking defects [37,38]. In this respect
it will be important to determine the impact of cytoskele-
tal rearrangements in Cln1-/- and Cln5-/- mice and
whether these result in similar intracellular trafficking
defects.
Conclusion
We verified our findings from the transcript profiles with
various methods to establish some functional support for
a "common pathway" in these two forms of NCL. A com-
mon signaling pathway connected to phosphorylation
and further affecting the cytoskeleton and growth cones in
neurons was revealed to be affected in both Cln1-/- and
Cln5-/- mice. Several genes coding for proteins in this
pathway were shown to be clustered on the same chromo-
somal region with the Ppt1 gene. These fndings provide a
possible mechanistic link between INCL and vLINCL dis-
eases. Indeed, because the role of the functionally unchar-
acterized Cln5 protein remains unclear these studies may
offer clues to the unraveling of its possible function(s).
Previous studies have concentrated on biochemical
approaches to find interaction partners for proteins and to
reveal the disease processes. We have here shown that
exposing affected metabolic pathways can provide an
alternative route to approach the functional roles of pro-
teins affected in genetic diseases.
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Additional file 1
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